Olivieri NF - Search Results

1

Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease.

Berkovitch M, Papadouris D, Shaw D, Onuaha N, Dias C, Olivieri NF. Berkovitch M, et al. Among authors: olivieri nf. Br J Clin Pharmacol. 1998 Jun;45(6):605-7. doi: 10.1046/j.1365-2125.1998.00730.x. Br J Clin Pharmacol. 1998. PMID: 9663818 Free PMC article. Clinical Trial.

2

Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator.

Matsui D, Hermann C, Klein J, Berkovitch M, Olivieri N, Koren G. Matsui D, et al. J Clin Pharmacol. 1994 Sep;34(9):944-9. doi: 10.1002/j.1552-4604.1994.tb04009.x. J Clin Pharmacol. 1994. PMID: 7983239 Clinical Trial.

3

Use of a eutectic mixture of local anesthetics for prolonged subcutaneous drug administration.

Berkovitch M, Davis S, Matsui D, Donsky J, Koren G, Olivieri NF. Berkovitch M, et al. Among authors: olivieri nf. J Clin Pharmacol. 1995 Mar;35(3):295-7. doi: 10.1002/j.1552-4604.1995.tb04062.x. J Clin Pharmacol. 1995. PMID: 7608320 Clinical Trial.

4

Iron-chelation therapy with oral deferiprone in patients with thalassemia major.

Olivieri NF, Brittenham GM, Matsui D, Berkovitch M, Blendis LM, Cameron RG, McClelland RA, Liu PP, Templeton DM, Koren G. Olivieri NF, et al. N Engl J Med. 1995 Apr 6;332(14):918-22. doi: 10.1056/NEJM199504063321404. N Engl J Med. 1995. PMID: 7877649 Free article. Clinical Trial.

5

Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function.

Berkovitch M, Bistritzer T, Milone SD, Perlman K, Kucharczyk W, Olivieri NF. Berkovitch M, et al. Among authors: olivieri nf. J Pediatr Endocrinol Metab. 2000 Feb;13(2):179-84. doi: 10.1515/jpem.2000.13.2.179. J Pediatr Endocrinol Metab. 2000. PMID: 10711663

6

Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation.

Robieux IC, Kellner JD, Coppes MJ, Shaw D, Brown E, Good C, O'Brodovich H, Manson D, Olivieri NF, Zipursky A, et al. Robieux IC, et al. Among authors: olivieri nf. Pediatr Hematol Oncol. 1992 Oct-Dec;9(4):317-26. doi: 10.3109/08880019209016603. Pediatr Hematol Oncol. 1992. PMID: 1467165 Clinical Trial.

7

Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease.

Collins AF, Fassos FF, Stobie S, Lewis N, Shaw D, Fry M, Templeton DM, McClelland RA, Koren G, Olivieri NF. Collins AF, et al. Among authors: olivieri nf. Blood. 1994 Apr 15;83(8):2329-33. Blood. 1994. PMID: 8161801 Free article.

8

Oxygen therapy in sickle cell disease.

Zipursky A, Robieux IC, Brown EJ, Shaw D, O'Brodovich H, Kellner JD, Coppes MJ, Koren G, Olivieri NF. Zipursky A, et al. Among authors: olivieri nf. Am J Pediatr Hematol Oncol. 1992 Aug;14(3):222-8. doi: 10.1097/00043426-199208000-00007. Am J Pediatr Hematol Oncol. 1992. PMID: 1510191 Clinical Trial.

9

Pharmacokinetics of arginine butyrate in patients with hemoglobinopathy.

Berkovitch M, Sher G, McCleland R, Matsui D, Hadzialic G, Olivieri NF, Koren G. Berkovitch M, et al. Among authors: olivieri nf. Environ Toxicol Pharmacol. 1996 Dec 20;2(4):403-5. doi: 10.1016/s1382-6689(96)00078-6. Environ Toxicol Pharmacol. 1996. PMID: 21781749

10

Arthropathy in thalassaemia patients receiving deferiprone.

Berkovitch M, Laxer RM, Inman R, Koren G, Pritzker KP, Fritzler MJ, Olivieri NF. Berkovitch M, et al. Among authors: olivieri nf. Lancet. 1994 Jun 11;343(8911):1471-2. doi: 10.1016/s0140-6736(94)92585-2. Lancet. 1994. PMID: 7911181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page